NEW YORK – B NOBLE Inc. and Curaleaf, an international provider of consumer products in cannabis, announced the expansion of its B NOBLE Cannabis Brand partnership into medical dispensary locations in New York. This expansion is one of the first partnerships of its kind in New York, as the New York Cannabis Control Board recently approved whole flower as part of its medical marijuana offerings in late October.
In collaboration with Fab 5 Freddy, New York native, filmmaker, visual artist and legendary hip-hop pioneer, and Bernard Noble, who spent seven years in prison for possession of two joints’ worth of cannabis flower, B NOBLE is a for-profit, cause-based cannabis brand. A part of Curaleaf’s corporate social responsibility program, Rooted in Good, B NOBLE is the company’s first large-scale brand venture in alignment with its dedicated social equity work. B NOBLE will bring a high-quality, Black-owned cannabis brand to the regulated cannabis market in New York, while advancing racial and social equity in the industry.
The brand is dedicated to telling the story of its namesake Bernard Noble, who was arrested in Louisiana and sentenced to 13 years in prison for possessing the equivalent of two joints. In 2017, Bernard’s case began to draw attention across the country, and he quickly became a national symbol for the need to reform the country’s unjust drug laws, sparking advocacy and a movement to free him. As a result, Bernard was released seven years into his sentence.
Since rolling out in July 2021, B NOBLE is now available in ten states including New York. Patients and consumers in adult-use and medical states can now purchase B NOBLE in Arizona, Colorado, Illinois, Maine, Massachusetts, Maryland, Michigan, Nevada, New York, and Oregon.
The New York market is the first to offer whole flower products as part of its B NOBLE product partnership, introducing 3.5G flower jars. At launch, two strains will be available, including Super Lemon Haze Cookies (Sativa) and Sour Diesel (Hybrid), with an additional Indica strain to arrive in stores later in December. Prior to October 2021, cannabis was only available to New York patients in ground form, a source of frustration for many patients who prefer the plant’s medicinal applications in its whole flower form.
Ten percent of proceeds from the sale of each B NOBLE product will go toward local organizations dedicated to advancing social equity and providing opportunities to those directly impacted by the War on Drugs. The team is seeking long term partnerships to ensure the brand continues to make an impact in New York, and potential partners are invited to reach out to [email protected]
“I’m thrilled and honored to be a part of B Noble’s expansion into my hometown, New York City”, said Fab 5 Freddy. “B NOBLE exists to generate support for the defense of people impacted by the War on Drugs, which is a War on People that took New York City by storm. It’s an honor to see B NOBLE active in New York, and working to right those wrongs of the drug war. It’s a full circle moment and a well-deserved moment for the community.”
More than 20 million Americans have been arrested for violating cannabis laws since 1970, and even though medical cannabis now is legal in the vast majority of states across the U.S., police still arrest people on cannabis-related charges at an alarming rate that disproportionately harms people of color. In 2020, people of color comprised 94 percent of those arrested for cannabis-related charges in New York City’s five boroughs, even though Black and white people use cannabis at similar rates.
Curaleaf’s mission is to improve lives by providing clarity around cannabis and confidence around consumption, driven by an 11-year history of serving medical patients. In order to ensure the development of an inclusive industry, this year Curaleaf launched Rooted in Good, led by Curaleaf Vice President of Corporate Social Responsibility Khadijah Tribble. Rooted in Good delivers social impact by focusing efforts within three key pillars: Diversity, Equity, and Inclusion; Social Equity; and Sustainability.
In addition to being sold in Curaleaf retail locations across New York, B NOBLE whole flower will also be available to the majority of the Company’s wholesale partners in the state. Curaleaf New York medical dispensaries are located in Carle Place, Hudson Valley, Plattsburgh and Queens.
Forward Looking Statements
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, “expects” or “proposed”, “is expected”, “intends”, “anticipates”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the launch of B Noble cannabis products. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under “Risk Factors and Uncertainties” in the Company’s latest annual information form filed April 28, 2021, which is available under the Company’s SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
(This information is primarily sourced from Curaleaf Holdings, Inc. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).